A detailed history of Acadian Asset Management LLC transactions in Rallybio Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 90,247 shares of RLYB stock, worth $89,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90,247
Previous 67,695 33.31%
Holding current value
$89,344
Previous $89,000 16.85%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.09 - $1.45 $24,581 - $32,700
22,552 Added 33.31%
90,247 $104,000
Q2 2024

Aug 06, 2024

BUY
$1.34 - $2.98 $48,777 - $108,474
36,401 Added 116.32%
67,695 $89,000
Q1 2024

May 10, 2024

BUY
$1.25 - $2.4 $39,117 - $75,105
31,294 New
31,294 $57,000
Q2 2022

Aug 09, 2022

BUY
$6.26 - $13.65 $63,776 - $139,066
10,188 New
10,188 $77,000

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $31.8M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.